2022 Mol. Neurobiol. paper by Fagan et al. reproduced the work of this preprint (published 2020 in IJMS (doi:10.3390/ijms21238957). They neither cited this preprint nor the IJMS paper! The good thing about it? They independently reproduced our work without even knowing it... ;-)
@SteveFagan88 @SpringerNature Thanks for your reply @SteveFagan88. We were at your poster at the Berlin FENS meeting in 2018. Our preprint was up since 2019 in bioRxiv. Funny you say you didn't see it when you submitted your 2022 paper. Please contact Molecular Biology and ask for correction. Thanks, Volkmar
Anti-inflammatory treatment with FTY720 starting after onset of symptoms reverses synaptic and memory deficits in an AD mouse model https://t.co/prKGs11qbx
Anti-inflammatory treatment with FTY720 starting after onset of symptoms reverses synaptic and memory deficits in an AD mouse model https://t.co/prKGs11qbx
@SteveFagan88 @SpringerNature Hi Steve, ...interesting, however, same approach, same results like in our 2020 paper. Why didn't you cite it?
"...FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model"
Int J Mol Sci. 2020 Nov 25;21(23):8957.
doi: 10.3390/ijms21238957
Anti-inflammatory treatment with FTY720 starting after onset of symptoms reverses synaptic and memory deficits in an AD mouse model https://t.co/fAuH7ugjDl